The global biomarkers market was valued at US$22.155 billion in 2017 and is expected to grow at a CAGR of 14.60% to reach a market size of US$43.793 billion by the year 2022. An indicator which measures some biological state or condition is called biomarker or biological marker. It is used for a substance which indicates presence of a living being. There are four types of biomarkers namely predisposition biomarkers which inform about the possibility of developing a health disorder. Other biomarker is diagnostic biomarker which is utilized to affirm that a patient has a specific health disorder earlier than any other physical examination of a patient. Prognostic biomarker helps to indicate the process of development of a disease in individual when a specific disorder is diagnosed in the patients body. The fourth type of biomarker is predictive biomarker which helps to identify patients which will get maximum benefits from following a specific treatment option.
The global market of biomarkers is primarily being driven by factors such as extensive applications of biomarkers, low cost of clinical trials and increased spending of government in research and development in medical field. Moreover, increased prevalence of diseases, boom of pharmaceuticals and biotech companies also impact the market growth significantly. On the contrary, poor regulation and reimbursement systems and requirement of huge funds to enter in the market restrains the market growth.
Geographically, North America is expected to drive the market on account of technological enhancements and continuous research and development activities in the region. Asia Pacific region will also contribute to the global growth owing to increasing prevalence of disease and ongoing expansion of pharmaceutical sector.
Firstly, the report provides a brief introduction of the market and deals with detailed research methodology for calculating market size and forecasts, secondary data sources used and the primary inputs which were taken for data validation. This section also outlines various segmentations which have been covered as part of the report.
Next, the section provides comprehensive market dynamics through an overview section along with growth drivers, challenges, and opportunities which exist in the current market. This section of the report also provides supplier and industry outlook as a whole; key industry, global and regional regulations which are determining the market growth and a brief technological aspect of Biomarkers. Complete industry analysis has also been covered by Porters five forces model as a part of this report section.
Thirdly, Biomarkers Market has been segmented on the basis of type, application and geography as follows:
Drug Discovery and Development
Disease Risk Assessment
Europe Middle East and Africa
Middle East and Africa
Finally, competitive intelligence section deals with major players in the market, their market shares, growth strategies, products, financials, and recent investments among others. Key industry players profiled as part of this section are Cisbio, MESO SCALE DIAGNOSTICS, LLC, PerkinElmer Inc., Bio-Rad Laboratories, QIAGEN, BioSIMS Technologies SaS, and Signosis Inc.
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.5. Supplier Outlook
4.6. Industry Outlook
4.7. Porters 5 Forces Analysis
4.8. Industry Value Chain Analysis
4.9. Industry Regulations
4.10. Scenario Analysis
5. Global Biomarkers Market Forecast by Type (US$ billion)
5.1. Safety Biomarkers
5.2. Validation Biomarkers
5.3. Efficacy Biomarkers
6. Global Biomarkers Market Forecast by Application (US$ billion)
6.1. Drug Discovery and Development
6.3. Disease Risk Assessment
6.4. Personalized Medicine
7. Global Biomarkers Market Forecast by Geography (US$ billion)
7.1.1. North America
7.1.2. South America
7.2. Europe Middle East and Africa
7.2.2. Middle East and Africa
7.3. Asia Pacific
8. Competitive Intelligence
8.1. Market Share of Key Players
8.2. Investment Analysis
8.3. Recent Deals
8.4. Strategies of Key Players
9. Company Profiles
9.2. MESO SCALE DIAGNOSTICS, LLC
9.3. PerkinElmer Inc.
9.4. Bio-Rad Laboratories
9.6. BioSIMS Technologies SaS
9.7. Signosis Inc.